The REACT-2 study at Imperial College London aims to estimate the prevalence of SARS-CoV-2 antibodies across England, to estimate the number of people that have had COVID-19.
The team have published their latest batch of data – it includes data from rounds 1-3 and includes self-testing antibody results from 365,000 people between 20 June and 28 September.
Note that this data is a preprint, so it is early work that has not yet been through peer-review and is not published in a journal.
Prof Paul Elliott, Director of the REACT programme, and Chair in Epidemiology and Public Health Medicine, Imperial College London
Prof Helen Ward, Professor of Public Health, Imperial College London
Prof Graham Cooke, Professor of Infectious Diseases, Imperial College London
Prof Wendy Barclay, Head of Department of Infectious Disease, and Action Medical Research Chair Virology, Imperial College London
This briefing is accompanied by an SMC Roundup of Comments.